Cosmetic Surgery Market Size to Worth US$ 205.1 Billion by 2030 – Exclusive Report by Precedence Research

According to Precedence Research, during the forecast period of 2022 to 2030, the global cosmetic surgery market is estimated to develop at a compound annual growth rate (CAGR) of 12.42%. The global cosmetic surgery market was valued at USD 71.5 billion in 2021, and it is predicted to exceed USD 205.1 billion by 2030. The study investigates several elements and their consequences on the growth of the cosmetic surgery market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/2083

This report focuses on cosmetic surgery market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall cosmetic surgery market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Report Scope of the Cosmetic Surgery Market

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of cosmetic surgery, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of cosmetic surgery has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the cosmetic surgery market.

Some of the prominent players in the cosmetic surgery market include:

• Evolus Inc.
• RevanceGalderma
• AbbVie
• Cynosure
• Lumenis
• Solta Medical
• Alma Laser
• Syneron Candela

Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/2083

Segments Covered in the Report

By Procedure

• Surgical Procedures
  • Breast Augmentation
  • Liposuction
  • Eyelid Surgery
  • Abdominoplasty
  • Rhinoplasty
  • Others
• Non-surgical Procedures
  • Botulinum Toxin
  • Hyaluronic Acid
  • Hair Removal
  • Nonsurgical Fat Reduction
  • Photo Rejuvenation
  • Others

By Gender

• Male
• Female

By Age 

• 13 – 29
• 30 – 54
• 55 plus

By End User

• Ambulatory Surgical Facility
• Hospital and Clinic
• Others

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cosmetic Surgery Market 

5.1. COVID-19 Landscape: Cosmetic Surgery Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cosmetic Surgery Market, By Procedure

8.1. Cosmetic Surgery Market, by Procedure, 2022-2030

8.1.1. Surgical Procedures

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Non-surgical Procedures

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Cosmetic Surgery Market, By Gender

9.1. Cosmetic Surgery Market, by Gender, 2022-2030

9.1.1. Male

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Female

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Cosmetic Surgery Market, By Age 

10.1. Cosmetic Surgery Market, by Age, 2022-2030

10.1.1. 13 – 29

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. 30 – 54

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. 55 plus

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Cosmetic Surgery Market, By End User 

11.1. Cosmetic Surgery Market, by End User, 2022-2030

11.1.1. Ambulatory Surgical Facility

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Hospital and Clinic

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Cosmetic Surgery Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.1.2. Market Revenue and Forecast, by Gender (2017-2030)

12.1.3. Market Revenue and Forecast, by Age (2017-2030)

12.1.4. Market Revenue and Forecast, by End User (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Gender (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Age (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.2.2. Market Revenue and Forecast, by Gender (2017-2030)

12.2.3. Market Revenue and Forecast, by Age (2017-2030)

12.2.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Gender (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Age (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Gender (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Age (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Gender (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Age (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.3.2. Market Revenue and Forecast, by Gender (2017-2030)

12.3.3. Market Revenue and Forecast, by Age (2017-2030)

12.3.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Gender (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Age (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Gender (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Age (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Gender (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Age (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.4.2. Market Revenue and Forecast, by Gender (2017-2030)

12.4.3. Market Revenue and Forecast, by Age (2017-2030)

12.4.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Gender (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Age (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Gender (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Age (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Gender (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Age (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Gender (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Age (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End User (2017-2030)

Chapter 13. Company Profiles

13.1. Evolus Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. RevanceGalderma

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. AbbVie

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Cynosure

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Lumenis

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Solta Medical

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Alma Laser

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Syneron Candela

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/2083

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com